Report #2896461

Received May 13, 2026

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Unknown
Age: Age unknown
State: WI
Recovered: Unknown
Vaccinated: —
Onset: —
Days to onset: —
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
HPV9	HPV (GARDASIL 9)	MERCK & CO. INC.	2	—	—

Symptoms (2)

Inappropriate schedule of product administrationNo adverse event

Symptom narrative

patient who received their second dose of GARDASIL 9 on day 63 from the timing of the first dose.; No additional AE; This spontaneous report was received from a pharmacist and refers to a 35-year-old patient of unknown gender. The patient's concurrent conditions, medical history, previous drug reactions, drug allergies and concomitant therapies were not reported. On an unknown date (On day 63 from the timing of the first dose), the patient was vaccinated with a second dose of Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL®9), 0.5 mL (route of administration, site of administration, lot #, and expiration date were not provided) given as prophylaxis (Inappropriate schedule of product administration). No additional AE. Additional information is not expected.